Shenzhen Haorui

Haorui Pharma, officially known as Shenzhen Haorui Industrial Co., Ltd., is a leading Chinese manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and high-end chemical intermediates. Founded in 2006, the company has developed a core competency in nucleoside and nucleotide chemistry, which are vital for antiviral and anti-cancer therapies. Their product catalog features intermediates for major drugs targeting Hepatitis B, HIV, and COVID-19, including Tenofovir and Remdesivir. Haorui operates several large-scale manufacturing sites and R&D facilities that comply with international GMP standards. By providing high-quality synthetic building blocks, the company serves as a critical partner for global pharmaceutical firms in drug development and commercial supply. Their expertise extends to complex multi-step synthesis and process optimization for small molecule therapeutics.